Article info
Screening
Original research
Population-based BRCA1/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study
- Correspondence to Professor Martin Delatycki, Murdoch Children's Research Institute, Parkville, VIC 3052, Australia; martin.delatycki{at}vcgs.org.au
Citation
Population-based BRCA1/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study
Publication history
- Received February 17, 2022
- Accepted May 17, 2022
- First published June 3, 2022.
Online issue publication
April 24, 2023
Article Versions
- Previous version (23 February 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.